权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

MaineHealth Cancer Care Network (MHCCN) and NCORP Activities across the Lifespan

MaineHealth 癌症护理网络 (MHCCN) 和 NCORP 整个生命周期的活动

基本信息

批准号：
10674780
负责人：
Leslie Bradford
金额：
$ 110.93万
依托单位：
MAINEHEALTH
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
起止时间：
2019-08-13 至 2025-07-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10674780
关键词：
Academic Medical Centers Adolescent and Young Adult Adult Arsenic Award Cancer Burden Cancer Center Cancer Control Cancer Control Research Cancer Model Cancer Patient Caring Cause of Death Child Childhood Clinical Clinical Research Clinical Trials Clinical Trials Network Communities Community Care Networks Community Clinical Oncology Program Complex Consensus Denmark Diagnosis Elderly Enrollment Environmental Exposure Evaluation Evolution Face Family Fostering Genomics Geography Goals Grant Growth Health Personnel Health system Healthcare Healthcare Systems High Prevalence Home Hospitals Human papilloma virus infection Incidence Infrastructure Institution Intervention Investments Lead Leadership Location Longevity Maine Malignant Childhood Neoplasm Malignant Neoplasms Medical Mission Morbidity - disease rate New England Obesity Occupational Oncology Operative Surgical Procedures Outcome Outcomes Research Participant Patient Participation Patient-Centered Care Patients Personal Satisfaction Population Prevention Prevention Research Process Productivity Provider Quality of life Radiation Radon Reporting Research Research Design Research Personnel Resources Risk Behaviors Rural Spain Specialist Strategic Planning Sun Exposure System Testing Therapeutic Time Translational Research anticancer research cancer care cancer clinical trial cancer genomics cancer health disparity cancer prevention cancer risk care delivery career development cigarette smoking community engagement community setting early phase trial end of life expectation improved inhibitor interdisciplinary approach member metropolitan mortality next generation oncology program outpatient facility patient oriented public health relevance research study response rural area rural cancer care rural setting screening socioeconomics survivorship trial enrollment

项目摘要

Abstract Maine ranks 12th and 8th in adult cancer incidence and mortality respectively, and pediatric cancer incidence rates are the third highest in the nation, contributing to marked cancer health disparities in our state. In 2018, it is estimated there will be 8,600 new adult cancer cases diagnosed in Maine; cancer is the most common cause of death in our state. Of these adult cases, 6,185 (72%) will receive their care at a MaineHealth Cancer Care Network (MHCCN) hospital or outpatient facility. This patient volume is akin to any major metropolitan cancer center. With only 1.3 million residents, Maine is a small state, is the most rural state, and has the oldest population in the nation. There are significant cancer risk behaviors and exposures, and there are numerous socioeconomic and geographic challenges as well, further compounding our cancer burden. The MHCCN is clearly organized around patient, health provider, and healthcare system multi-tiered strategies and interventions that are prioritized in the NCORP solicitation and defended in this proposal. Our health system embarked upon a comprehensive oncology strategic planning process in 2014 that in a relatively short period has led to the opportunity to submit our response to this FOA. Consensus was reached on the model of cancer care that we would pursue. The singular goal is to ensure that "the right care, in the right location, as close to home as possible" will be provided. Cancer patients in our state and their families desire access to state-of-the-art patient-centered care. This NCORP application could not come at a more auspicious time for our organization, coinciding with significant growth and substantive multi- million dollar investment in MH Oncology over the past couple years. With this backdrop, the fundamental goal of our application is to commit and contribute to a robust slate of NCORP activities across the lifespan including pediatric, adolescent and young adults, adults, and elderly cancer patients in our communities and rural care settings. We have assembled a highly interactive and interdisciplinary team across our network to participate in and lead this research endeavor. Our central hypothesis is that developing a highly interactive and interdisciplinary approach to cancer care that is at all times patient-centered throughout MH Oncology will have salutary effects on all aspects of our cancer care across the continuum of prevention, screening, diagnosis, treatment, survivorship, end-of-life, and care delivery not only for our patients and their families but for other aspects critical to our mission – including educating the next generation of healthcare providers and expanding our research pursuits especially in rural areas within our care network. We propose 4 aims: To conduct and actively participate in 1) cancer control research, 2) cancer prevention research, and 3) cancer care delivery research studies; and 4) to capitalize upon clinical research opportunities afforded by NCORP and our newly awarded Northern New England Clinical and Translational Research Network grant (1U54 GM115517). We will pursue these aims across the lifespan engaging both children and adults. The MHCNN has every expectation that will we make substantive contributions across the spectrum of the NCORP research portfolio. We will capitalize on our institutional assets, patient resources, and expertise from the vantage point of community and rural settings to add value across the lifespan and provide leadership to the NCORP. We welcome and value the opportunity to join the NCORP network as a new institutional member.

摘要